Drug-Eluting Stents Lead Product Segment in Cardiac Interventions The global interventional cardiology market is experiencing a period of dynamic transformation, driven by the increasing prevalence of cardiovascular diseases (CVDs), a growing geriatric population, and accelerated advancements in minimally invasive cardiac procedures. Valued at USD 16.35 billion in 2023, the market is projected to expand to USD 24.55 billion by 2031, growing at a compound...
0 Поделились
10 Просмотры
0 предпросмотр